Adults (18-65), Geriatrics (65+)
English and Dutch
Adults (18-65), Geriatrics (65+)
English and Dutch
Internal Medicine, 2011
Medical Oncology, 2016
Perelman Center for Advanced Medicine
West Pavilion, 2nd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
James J. Harding; Hooman Yarmohammadi; Kim A. Reiss; Joanne F. Chou; Marinela Capanu; Richard K. Do; Danny N. Khalil; Imane El Dika; Daniel Giardina; Taha Merghoub; William R. Jarnagin; Gregory Nadolski; Joseph P. Erinjeri; Michael C. Soulen; Benjamin Tan; Ghassan K. Abou-Alfa: Nivolumab and drug eluting bead transarterial chemoembolization (deb-TACE): Preliminary results from a phase I study of patients with liver limited hepatocellular carcinoma ASCO GI Meeting, San Francisco, CA : 2020.
Erin M. Bange MD, Abigail Doucette MPH, Peter E. Gabriel. MD MS, Florence Porterfield, James J. Harrigan MD PharmD, Robin Wang, Andrez P. Wojcieszynski MD, Ben Boursi MD, 2, Bethany I. Mooney CRNP, Kim A. Reiss, MD*, Ronac Mamtani MD MSCE*: Opportunity costs of receiving palliative chemotherapy for metastatic pancreatic ductal adenocarcinoma JCO Oncology Practice : 2020.
Max Wattenberg, Daniella Asch, Shun Yu, Peter O’Dwyer, Susan Domchek, Katherine Nathanson, Mark Rosen, Gregory L Beatty, Evan Siegelman, and Kim Reiss: Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation British Journal of Cancer : 2019.
Ofer Margalit, Ronac Mamtani, Yaacov Lawrence, Yu-Xiao Yang, Bruce Giantonio, Talia Golan, Dan Aderka, Naama Halpern, Kim Reiss, Einat Shacham-Shmueli, Ben Boursi: Post-Operative Radiation for Pathologic Stage T4 Colon Cancers Receiving Adjuvant Chemotherapy Clinical Colorectal Cancer : 2019.
Ben Boursi, Bruce Giantonio, Dan Aderka, Einat Shacham-Shmueli, Kim Reiss, Naama Halpern, Ofer Margalit, Raashi Mamtani, Talia Golan, Yu-Xiao Yang, Yaacov Lawrence: Lung Metastasis Predicts Better Prognosis in Metastatic Colorectal Cancer with Mutated KRAS Clinical Colorectal Cancer : 2019.
Erin Bange, Abigail Doucette, Peter Gabriel, Robin Wang, Andrzej P Wojcieszynski, Bethany Mooney, Ben Boursi, Kim Anna Reiss, Ronac Mamtani: Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma(mPDAC) International Conference on Pharmacoepidemiology and Therapeutic Risk Management : 2019.
Kim A. Reiss, MD; Rosemarie Mick, MS; Mark O’Hara, MD; Ursina Teitelbaum, MD; Thomas Karasic, MD; Charles Schneider, MD; Peter O’Dwyer, MD; Danielle Karlson, RN; Stacy Cowden, RN; Mary Jane Fuhrer, BA; Erica Carpenter, PhD; Austin Pantel, MD; Mehran Makvandi, PharmD; David Mankoff, MD, PhD; Katharine Nathanson, MD; Kara Maxwell, MD, PhD; Gregory Beatty, MD, PhD; Susan Domchek, MD: A Randomized Phase II Trial of Niraparib Plus Either Nivolumab or Ipilimumab in Patients with Platinum Sensitive, Advanced Pancreatic Cancer
ASCO Annual Meeting, Chicago, IL : 2019.
Margalit O, Mamtani R, Lawrence YR, Yang YX, Baruch EN, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B.: Locally advanced rectal adenocarcinoma: Are preoperative short and long course radiotherapy truly equivalent? Molecular and Clinical Oncology : 2019.
Thomas B. Karasic, MD; Mark O'Hara, MD; Arturo Loaiza-Bonilla, MD; Kim A. Reiss, MD; Ursina R. Teitelbaum, MD; Erkut Borazanci, MD; Ana De Jesus-Acosta, MD; Colleen Redlinger, BA; Jessica A. Burrell, BA; Daniel A. Laheru, MD; Daniel D. Von Hoff, MD; Ravi K. Amaravadi, MD; Jeffrey A. Drebin, MD, PhD; Peter J. O’Dwyer, MD: Randomized Phase II Trial of Gemcitabine and 'nab-Paclitaxel With or Without Hydroxychloroquine in Advanced Pancreatic Cancer JAMA Oncology : 2019.
Stéphanie L. Gaillard, MD, PhD; Marianna Zahurak; Anup Sharma; Kim Reiss, MD; Susan Sartorius; Melinda Downs; Nicole M. Anders; Nita Ahuja, MD; Michelle A. Rudek, PhD1; Nilofer Azad, MD: A phase I trial of oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors Cancer : 2019.
Division of Hematology OncologyPerelman Center for Advanced Medicine10th Floor, South PavilionOffice #10-3053400 Civic Center Blvd
Phone: (215) 360-0735
Patient appointments: 800-789-7366
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.